Hanly, Paul, Pearce, Alison and Sharp, Linda (2014) The cost of premature cancer-related mortality: a review and assessment of the evidence. Expert Review of Pharmacoeconomics & Outcomes Research, 14 (3). pp. 355-377. ISSN 1744-8379Full text not available from this repository.
Worldwide, 8.2 million people die of cancer annually. Cancer has a significant societal impact, impinging on countries' economic health. We reviewed methodological aspects, and the main cost results, of studies calculating premature mortality losses from cancer published 2000–2013 and identified gaps in the evidence-base. Thirty-one studies were identified (Europe, 17; USA, 11; Korea, 2; Puerto Rico, (1). The human capital approach dominated (30 studies); studies differed in how they implemented the methodological approach. Aspects of methodology were poorly reported. Premature cancer-related mortality costs are substantial and appear to be rising. The evidence-base has gaps in relation to cancer sites studied and less developed and emerging economies. Comprehensive, standardised, estimates of premature mortality losses are needed if these measures are to be useful in assessing the societal cancer burden.
|Subjects:||Q Science > Life sciences > Medical sciences > Pathology > Tumors > Cancer
H Social Sciences > Economics > Microeconomics > Production (Economic theory) > Industrial productivity > Labor productivity
|Divisions:||School of Business > Staff Research and Publications|
|Depositing User:||CAOIMHE NI MHAICIN|
|Date Deposited:||12 Sep 2014 13:04|
|Last Modified:||12 Sep 2014 13:41|
Actions (login required)